Choreo, LLC Rani Therapeutics Holdings, Inc. Transaction History
Choreo, LLC
- $6.88 Billion
- Q4 2024
A detailed history of Choreo, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Choreo, LLC holds 11,813 shares of RANI stock, worth $18,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,813Holding current value
$18,428% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.11 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$769,9910.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$699,6470.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$472,2790.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$454,5540.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $38.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...